Lunai Bioworks Inc. (LNAI) News
Follow Lunai Bioworks Inc. (LNAI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 12 public stories across 10 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Nasdaq Moves to Delist Lunai Bioworks Over Equity Requirement
Nasdaq said Lunai Bioworks failed to meet the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1) and determined to delist its securities. Trading could be suspended October 30 unless the company
REGULATION | Oct 23, 2026, 10:03 AM UTC
M
Lunai Bioworks requests Nasdaq trading halt
The company requested Nasdaq immediately suspend trading in its common stock while alleged irregular trading is reviewed.
EQUITY | Oct 09, 2026, 06:03 PM UTC
H
Stock Market: Will S&P 500 Open Up or Down Today?
U.S. stock futures are trending higher early Friday as investors brace for the critical September jobs report and monitor widening U.S. sanctions against Iran amid escalating bond market jitters. The Polymarket (CRYPTO:
LIVE | Oct 02, 2026, 05:47 AM UTC
H
Lunai Bioworks Files For Non Timely 10-K With U.S. SEC; Anticipates Reporting A Net Loss For The Fiscal Year Ended June 30, 2026 Of ~$3.2M
The Company anticipates reporting a net loss for the fiscal year ended June 30, 2026 of approximately $3.2 million, compared to a net loss of approximately $178.0 million for the fiscal year ended June 30, 2025. The anti
LIVE | Sep 29, 2026, 08:55 PM UTC
L
Lunai Bioworks signs exclusive Tanaist deal to expand Parkinson’s platform
Lunai Bioworks (Nasdaq: LNAI) says an exclusive worldwide agreement with Tanaist adds human cellular validation to its AI-driven Parkinson’s workflow, linking patient-derived subtypes with disease mechanisms, biomarkers
EQUITY | Sep 22, 2026, 01:20 PM UTC
L
LNAI - Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
LNAI - Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
NEWS | Sep 16, 2026, 01:25 PM UTC
L
Lunai Bioworks issues correction to prior press release link
Lunai Bioworks issued a correction to its prior press release, updating a reference link. The company said no other content in the original release has changed.
EQUITY | Sep 04, 2026, 01:21 PM UTC
L
Lunai Bioworks issues correction to press release on second amended complaint
Lunai Bioworks issued a correction to its press release regarding a second amended complaint.
EQUITY | Sep 04, 2026, 01:20 PM UTC
L
Lunai Bioworks names six broker-dealers in expanded naked short suit
Lunai Bioworks says it has named six broker-dealers in an expanded naked short selling suit.
EQUITY | Aug 27, 2026, 01:27 PM UTC
M
Lunai Bioworks Signs Collaboration Agreement
Lunai Bioworks partners with BrainStorm Therapeutics
EQUITY | Aug 04, 2026, 07:30 PM UTC
H
Lunai Bioworks Names 10 Defendants in Fraud Suit
Lunai Bioworks sues 10 defendants for naked short selling
EQUITY | Aug 04, 2026, 01:20 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Monday's pre-market session, with gains and losses across the sector
EQUITY | Jun 22, 2026, 12:08 PM UTC